Viatris (VTRS) EBIT Margin (2019 - 2026)
Viatris' (VTRS) quarterly EBIT Margin came in at 2.27% in Q1 2026, up 8630.0% year-on-year from 0.03% in Q1 2025, and up 55.92% quarter-over-quarter from 5.15% in Q4 2025.
Viatris (VTRS) EBIT Margin (2019 - 2026) Analysis & Trends
Viatris' EBIT Margin history runs 8 years deep, the most recent figure standing at 2.27% for Q1 2026.
- On a quarterly basis, EBIT Margin rose 8630.0% year-over-year to 2.27% in Q1 2026; TTM through Mar 2026 was 0.96%, a 2251.0% increase from a year earlier, with the FY2025 full-year figure at 18.62%, down 1869.0% from the prior year.
- EBIT Margin grew to 2.27% in Q1 2026 per VTRS's latest filing, from 5.15% in the prior quarter.
- Across five years, EBIT Margin topped out at 16.93% in Q1 2022 and bottomed at 88.57% in Q1 2025.
- The 5-year median for EBIT Margin is 5.57% (2024), against an average of 1.53%.
- Across the five-year window, EBIT Margin sank 9413 bps in 2025 and surged 8630 bps in 2026, its largest moves.
- Year by year, EBIT Margin stood at 5.15% in 2022, then plunged by 132 bps to 11.96% in 2023, then surged by 57 bps to 5.16% in 2024, then gained by 0 bps to 5.15% in 2025, then jumped by 56 bps to 2.27% in 2026.
- Per Business Quant, the three latest VTRS EBIT Margin figures stand at 2.27% (Q1 2026), 5.15% (Q4 2025), and 4.76% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 8.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.27% |
| Dec 31, 2025 | -5.15% |
| Sep 30, 2025 | 4.76% |
| Jun 30, 2025 | 6.53% |
| Mar 31, 2025 | -88.57% |
| Dec 31, 2024 | -5.16% |
| Sep 30, 2024 | 6.02% |
| Jun 30, 2024 | -6.34% |
| Mar 31, 2024 | 5.57% |
| Dec 31, 2023 | -11.96% |
| Sep 30, 2023 | 11.48% |
| Jun 30, 2023 | 9.42% |
| Mar 31, 2023 | 10.72% |
| Dec 31, 2022 | -5.15% |
| Sep 30, 2022 | 13.77% |
| Jun 30, 2022 | 13.37% |
| Mar 31, 2022 | 16.93% |
| Dec 31, 2021 | -1.76% |
| Sep 30, 2021 | 7.91% |
| Jun 30, 2021 | -1.05% |